Glenmark settles drug pricing case with US Department of Justice
US-based Glenmark Pharmaceuticals Inc, a subsidiary of the company, has entered into a three-year deferred prosecution agreement with DOJ involving historical pricing practices by former employees relating to the generic drug pravastatin between 2013 and 2015 (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 22, 2023 Category: Pharmaceuticals Source Type: news
Generic drug giants settle federal price-fixing charges
The two companies both agreed to sell off their operations making the cholesterol drug pravastatin. Companies typically pay criminal fines to settle antitrust charges rather than selling off lines of business. “Today, the Antitrust Division and our law enforcement partners hold two more…#antitrustdivision #jonathankanter #justicedepartments #teva #glenmark #sanjeevkrishan #novartis #sandoz #taropharmaceuticals #philadelphia (Source: Reuters: Health)
Source: Reuters: Health - August 21, 2023 Category: Consumer Health News Source Type: news
Statins side effects: Experiencing pain in three areas of the body? Speak to your doctor
THE NHS says there are five types of statin available on prescription in the UK. They include atorvastatin, fluvastatin pravastatin, rosuvastatin and simvastatin. According to the Mayo Clinic, you check in with your doctor if you experience pain in three areas of the body while on statins. (Source: Daily Express - Health)
Source: Daily Express - Health - May 12, 2022 Category: Consumer Health News Source Type: news
Pravastatin cost effective for preventing atherosclerotic CVD in people with HIV
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2021 Category: Drugs & Pharmacology Source Type: news
Pravachol (pravastatin)
Title: Pravachol (pravastatin)Category: MedicationsCreated: 10/13/2020 12:00:00 AMLast Editorial Review: 10/13/2020 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - October 13, 2020 Category: Cardiology Source Type: news
International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A
International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg tablets. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 20, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Use of a homozygous G608G progeria mouse model for degenerative joint diseases research
(Beth Israel Deaconess Medical Center) In a study published today in the journal Proceedings of the National Academies of Science, researchers led by Ara Nazarian, PhD, a principal investigator in the Center for Advanced Orthopaedic Studies at BIDMC, investigated the musculoskeletal phenotype of the homozygous G608G BAC-transgenic progeria mouse model, developed at Dr. Collins' lab at the National Institutes of Health, and determined the phenotypic changes of these mice after a five-arm preclinical trial of different treatment combinations with lonafarnib, pravastatin, and zoledronic acid. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2020 Category: International Medicine & Public Health Source Type: news
pravastatin (Pravichol)
Title: pravastatin (Pravichol)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/10/2019 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - July 10, 2019 Category: Cardiology Source Type: news
Statins cut heart deaths in men by 28% finds study
Conclusion
This new analysis found that men without cardiovascular disease who were prescribed a statin were less likely to go on to develop heart disease or have a major cardiovascular event.
These findings from the five-year randomised controlled trial are useful – there's been a lot of debate about whether giving statins to people without any cardiovascular disease is helpful.
But it's harder to draw conclusions from the longer term results, as these were from a non-randomised observational period. Potential confounding factors – such as the men's attitude to medicine, risk and health – may have influenced the res...
Source: NHS News Feed - September 7, 2017 Category: Consumer Health News Tags: Heart/lungs Source Type: news
Pravastatin Recalled Over Bupropion Mix-Up (FREE)
By the Editors
One lot of pravastatin tablets (40 mg, 30-tablet bottles) manufactured by International Laboratories, LLC has … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 14, 2017 Category: Primary Care Source Type: news
Pravastatin Tablets Recalled, Contain Antidepressant Pravastatin Tablets Recalled, Contain Antidepressant
One lot of the cholesterol-lowering statin was mislabeled and instead contains an antidepressant.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 11, 2017 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news
International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A
International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg tablets. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 10, 2017 Category: Food Science Source Type: news
Pravastatin Doesn't Improve Clinical Outcomes in Seniors (FREE)
By Kelly Young
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Older adults with hypertension and hyperlipidemia might not benefit from taking pravastatin for primary prevention of cardiovascular events, according to an open-label study in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 22, 2017 Category: Primary Care Source Type: news
Study Casts Doubt on Need for Statins in the'Healthy Old '
MONDAY, May 22, 2017 -- Senior citizens with no history of heart problems appear to gain no health benefit from cholesterol-lowering statin drugs, a new study suggests.
People 65 and older treated with pravastatin (Pravachol) as part of a major... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 22, 2017 Category: General Medicine Source Type: news
Pitavastatin an Option for High LDL-C With Antiretrovirals for HIV Pitavastatin an Option for High LDL-C With Antiretrovirals for HIV
It seemed more potent against LDL than pravastatin in a small trial; other statins may interfere with some anti-HIV drugs. Virologic failure or serious adverse events weren ' t seen with either statin.Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 24, 2017 Category: Cardiology Tags: Cardiology News Source Type: news
